Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC

Authors: Tianqing Chu, Runbo Zhong, Hua Zhong, Bo Zhang, Wei Zhang, Chunlei Shi, Jialin Qian, Yanwei Zhang, Qing Chang, Xueyan Zhang, Yu Dong, Jiajun Teng, Zhiqiang Gao, Huiping Qiang, Wei Nie, Yiming Zhao, Yuchen Han, Ya Chen, Baohui Han - Journal of Thoracic Oncology 2021 cited by 226